Step 1 Renal
Renal is one of the most physiology-heavy areas on USMLE Step 1. Expect questions on GFR regulation, tubular transport, acid-base disorders, and diuretic mechanisms — often as standalone physiology questions but just as often embedded in clinical vignettes about AKI, electrolyte emergencies, or a patient starting an ACE inhibitor. The exam rewards students who can trace a perturbation (volume depletion, a new drug, CKD) through the entire system to predict lab values and clinical consequences. If you are looking for high-yield renal physiology and acid-base topics for Step 1, nephron segment transport and the anion-gap differential are the two clusters tested most frequently.
Glomerular disease is tested almost exclusively through vignettes. You need to distinguish nephritic from nephrotic syndromes, then narrow the differential using biopsy findings — light microscopy, immunofluorescence pattern, and electron microscopy — plus complement levels and clinical context. Students consistently confuse subepithelial humps (PSGN) with spike-and-dome deposits (membranous nephropathy), and granular IF (immune complex) with linear IF (anti-GBM) — those are the exact swaps the exam uses to separate correct from incorrect answers.
Step 1 acid-base and electrolyte questions are high-yield and frequently mixed with pharmacology — a diuretic question is also a potassium question, a compensation question, and sometimes a clinical management question. Another common misconception: students assume vomiting causes hypokalemia by direct gastric potassium loss, when the real mechanism is renal potassium wasting driven by metabolic alkalosis and volume contraction. The tricky part is that USMLE renal questions test second-order reasoning: not just what a drug does, but what happens when you combine it with bilateral renal artery stenosis, or what the ECG shows before you act.
Kidney Development (Pro-/Meso-/Metanephros)
Three kidney precursors in sequence, which structures give rise to nephrons versus collecting system, and why horseshoe kidneys arrest at the IMA.
- Confuses pronephros as a functional precursor to the adult kidney
- Confuses ureteric bud with metanephric mesenchyme as the source of nephron tubules
Congenital Renal Anomalies
Potter sequence, horseshoe kidney, duplex ureters with the Weigert-Meyer rule, and why unilateral MCDK is survivable.
- Confuses cause of death in Potter sequence as renal failure rather than pulmonary hypoplasia
- Inverts the Weigert-Meyer insertion rule for duplex collecting system ureters
Nephron Structure and Segments
Segment order from glomerulus to collecting duct, cortex-versus-medulla locations, and why juxtamedullary nephrons concentrate urine.
- Conflates the DCT with the collecting duct as a single distal segment
- Assumes the entire loop of Henle is medullary, missing that the TAL ascends into the cortex
Renal Vasculature (Afferent / Efferent / Vasa Recta)
Two capillary beds in series, pressure roles of afferent and efferent arterioles, and vasa recta countercurrent exchange.
- Misses the second capillary bed by assuming efferent arteriole drains directly to venous circulation
- Attributes active transport to vasa recta rather than passive countercurrent exchange
Juxtaglomerular Apparatus
JG cells versus macula densa roles, three independent renin-release stimuli, and tubuloglomerular feedback direction.
- Attributes renin secretion to macula densa rather than to JG (granular) cells
- Inverts tubuloglomerular feedback, thinking high NaCl delivery increases rather than decreases GFR
GFR Determinants and Regulation
Starling forces at the glomerulus, how afferent and efferent tone shift GFR and filtration fraction, and why ACEi precipitates AKI in bilateral RAS.
- Incorrectly predicts that efferent constriction decreases GFR, ignoring the rise in glomerular hydrostatic pressure
- Attributes ACEi-induced AKI in bilateral RAS to systemic hypotension rather than loss of efferent arteriolar tone
Renal Clearance and Measurement of GFR
Clearance formula logic, why creatinine overestimates GFR, and how PAH clearance yields effective renal plasma flow.
- Assumes creatinine clearance equals GFR, ignoring tubular secretion of creatinine
- Misinterprets Cx > Cinulin as enhanced filtration rather than tubular secretion
Proximal Tubule Transport
Bulk reabsorption in the PCT, SGLT transport maximum and glucosuria threshold, HCO₃⁻ reclamation via the CO₂ shuttle, and Fanconi syndrome.
- Misidentifies glucose PCT uptake as primary active transport rather than Na+-coupled secondary active transport via SGLT
- Thinks HCO3− crosses the luminal membrane directly rather than being reclaimed via the CO2 shuttle
Loop of Henle Transport
Permeability differences across loop segments, NKCC2 and ROMK recycling in the TAL, medullary gradient generation, and Bartter syndrome.
- Inverts water permeability of descending vs ascending limb of Henle
- Misidentifies ROMK K+ recycling direction as intracellular rather than back into the lumen
Distal Convoluted Tubule Transport
NCC cotransporter, thiazide-induced hypocalciuria mechanism, and Gitelman syndrome electrolyte pattern.
- Confuses the target of loop diuretics (NKCC2/TAL) with the DCT NCC transporter
- Inverts the effect of thiazides on urinary calcium, predicting hypercalciuria instead of hypocalciuria
Collecting Duct Transport
Principal versus intercalated cell transporters, aldosterone's genomic effect on ENaC and K⁺ channels, and ADH-driven AQP2 vesicle insertion.
- Confuses principal cell and intercalated cell roles in the collecting duct
- Confuses aldosterone's genomic mechanism with direct channel gating
Renin-Angiotensin-Aldosterone System
Full angiotensinogen-to-aldosterone cascade, drug block points, preferential efferent constriction by ATII, and primary versus secondary hyperaldosteronism patterns.
- Mislocates ACE activity to the kidney rather than the pulmonary vasculature
- Confuses equal arteriolar constriction with preferential efferent constriction by angiotensin II
ADH, Free Water Regulation, and ADH-Active Drugs
Osmoreceptor-to-AQP2 axis, V1 versus V2 receptor signaling, SIADH criteria, and desmopressin response distinguishing central from nephrogenic DI.
- Confuses V1 (Gq/vasoconstriction) and V2 (Gs/cAMP/AQP2) receptor signaling pathways
- Confuses SIADH with a dilute-urine state; SIADH produces concentrated urine despite hyponatremia
Renal Hormones (EPO, Calcitriol, Renin)
Peritubular fibroblast EPO production, two-step vitamin D hydroxylation, and what CKD loses at each step.
- Misattributes EPO production to tubular cells rather than peritubular interstitial fibroblasts
- Confuses the order of vitamin D hydroxylation steps between liver and kidney
Potassium Handling and Regulation
Transcellular shift drivers, why loop and thiazide diuretics waste potassium indirectly, and the stabilize-shift-remove sequence for hyperkalemia.
- Confuses insulin's transcellular K+ shift mechanism with renal K+ excretion
- Confuses indirect flow-mediated K+ wasting with direct K+ transport blockade by loop/thiazide diuretics
Calcium and Phosphate Handling (PTH / Vitamin D)
PTH actions across bone, DCT, and PCT; calcitriol's intestinal-first calcium mechanism; and FGF23 suppression of 1α-hydroxylase.
- Confuses PTH's phosphaturic effect in the PCT with calcium-retaining effect in the DCT
- Overemphasizes bone resorption and underemphasizes intestinal absorption as calcitriol's primary calcium-raising mechanism
Renal Acid-Base Handling
PCT bicarbonate reclamation via H⁺ secretion, new bicarbonate generation by α-intercalated cells, and NH₄⁺ excretion as the dominant chronic buffer.
- Confuses indirect HCO3− reclamation via H+ secretion with direct HCO3− transport in the PCT
- Confuses new bicarbonate generation by α-intercalated cells with simple bicarbonate reabsorption
Nephritic Syndrome — Pattern and Differential
Hematuria, hypertension, and oliguria from glomerular inflammation; how RBC casts form; and the immune complex–complement–inflammatory axis.
- Misattributes nephritic hematuria to tubular rather than glomerular injury
- Confuses the proteinuria threshold of nephritic syndrome with that of nephrotic syndrome
Post-Streptococcal Glomerulonephritis (PSGN)
Post-infectious latency, subepithelial humps on EM, low C3 with normal C4, and distinction from synpharyngitic IgA nephropathy.
- Confuses PSGN's post-infectious latency with IgA nephropathy's synpharyngitic timing
- Confuses PSGN's alternative pathway complement pattern with lupus nephritis's classical pathway pattern
IgA Nephropathy (Berger Disease)
Synpharyngitic hematuria, mesangial IgA on immunofluorescence, and the risk of progressive CKD unlike self-limited PSGN.
- Confuses IgA nephropathy's synpharyngitic onset with PSGN's post-infectious latency
- Confuses IgA nephropathy's mesangial IgA IF pattern with IgG deposition
Rapidly Progressive GN (Crescentic)
Crescent formation by parietal epithelium and macrophages, three immunofluorescence patterns with their diseases, and the α-3 collagen IV target in Goodpasture.
- Confuses crescent cellular origin (parietal epithelium + macrophages) with mesangial proliferation
- Confuses linear IF pattern (anti-GBM) with granular IF pattern (immune-complex RPGN)
Alport Syndrome and Thin Basement Membrane Disease
X-linked collagen IV mutation, basket-weave EM pattern with sensorineural hearing loss, and benign prognosis of thin basement membrane disease.
- Conflates Alport collagen IV mutation with Goodpasture anti-GBM antibody target
- Confuses Alport basket-weave EM pattern with the uniform thinning seen in thin basement membrane disease
Membranoproliferative GN (MPGN)
Tram-track GBM duplication from mesangial interposition, type I immune complex versus type II C3NeF pathogenesis, and differing complement patterns.
- Misattributes tram-track GBM duplication to deposits rather than mesangial interposition
- Confuses MPGN type II pathogenesis (C3NeF/alternative pathway) with type I immune complex deposition
Lupus Nephritis
ISN/RPS class III versus IV distinction by glomerular percentage, full-house immunofluorescence, and classical pathway activation with low C3 and C4.
- Confuses class III (focal, <50% glomeruli) with class IV (diffuse, >50% glomeruli) as the most severe lupus nephritis
- Misassigns lupus nephritis to alternative pathway; it activates classical pathway with low C3 and low C4
Nephrotic Syndrome — Pattern and Differential
Proteinuria above 3.5 g/day with edema, hypoalbuminemia, hyperlipidemia, and antithrombin III loss driving thrombosis risk.
- Attributes nephrotic thrombosis risk to hyperviscosity from hyperlipidemia rather than urinary loss of antithrombin III
- Oversimplifies nephrotic edema as pure oncotic pressure loss; misses secondary RAAS-driven sodium retention component
Minimal Change Disease
Normal light microscopy, negative IF, and foot process effacement on EM; steroid-responsive but relapsing; adult cases warrant lymphoma workup.
- Expects IF deposits in MCD; IF is negative and diagnosis rests on EM foot process effacement
- Expects subtle LM abnormalities in MCD; LM is entirely normal and diagnosis requires EM
Focal Segmental Glomerulosclerosis (FSGS)
Focal and segmental sclerosis by definition, collapsing variant with HIV/heroin, and higher steroid resistance and ESRD risk than MCD.
- Misinterprets focal/segmental terminology: focal = subset of glomeruli, segmental = portion of each affected glomerulus
- Misses that collapsing FSGS variant is specifically linked to HIV/heroin and shows capillary tuft collapse with podocyte hyperplasia
Membranous Nephropathy
Spike-and-dome subepithelial deposits, PLA2R antibody in primary disease, and HBV as the viral secondary cause — not HCV.
- Inverts PLA2R interpretation: positive PLA2R = primary disease; negative PLA2R = search for secondary cause
- Missing that HBV (not HCV) is the viral secondary cause of membranous nephropathy; HCV causes MPGN
Diabetic Nephropathy
Kimmelstiel-Wilson nodules as mesangial matrix expansion, early hyperfiltration before GFR falls, and ACEi renoprotection via efferent dilation.
- Misidentifies Kimmelstiel-Wilson nodules as immune deposits; they are nodular mesangial matrix expansion from glycosylation injury
- Expects early GFR reduction in diabetic nephropathy; early disease shows hyperfiltration with elevated GFR
Acute Tubular Necrosis (ATN)
Muddy brown granular casts, ischemic PCT/TAL vulnerability, three clinical phases, and why FENa is unreliable in contrast and myoglobin injury.
- Confuses ATN urinalysis finding (muddy brown granular casts) with RBC casts seen in glomerulonephritis
- Over-relies on FENa >2% for ATN diagnosis; FENa can be misleadingly low in contrast nephropathy and myoglobinuria-induced ATN
Acute Interstitial Nephritis (AIN)
Allergic triad rarely complete, eosinophiluria unreliable, NSAID-induced AIN lacks the classic triad, and steroid-responsive if caught early.
- Assumes the classic AIN triad is reliably present rather than rarely complete
- Treats eosinophiluria as a reliable diagnostic marker for AIN
AKI Classification (Pre-/Intrinsic/Post-renal)
Pre-renal versus intrinsic versus post-renal differentiation by FENa and urine indices, FEUrea in diuretic use, and why bilateral obstruction is needed for azotemia.
- Treats FENa <1% as synonymous with pre-renal AKI regardless of clinical context
- Uses FENa to classify AKI in a patient on loop diuretics instead of switching to FEUrea
Chronic Kidney Disease and Consequences
eGFR staging, CKD-MBD cascade from hyperphosphatemia through low calcitriol, EPO deficiency anemia, and uremic indications for dialysis.
- Identifies hypocalcemia rather than hyperphosphatemia and low calcitriol as the initiating event in CKD-MBD
- Attributes CKD anemia to iron deficiency rather than EPO deficiency
Hepatorenal Syndrome
Splanchnic vasodilation triggering renal vasoconstriction in cirrhosis, exclusion of other AKI causes, and liver transplant as the only cure.
- Attributes HRS to direct renal toxicity rather than functional renal vasoconstriction from splanchnic vasodilation
- Identifies vasopressor-albumin therapy as definitive rather than as a bridge to liver transplantation
Nephrolithiasis (Kidney Stones)
Stone composition, urine pH associations, crystal morphology, urease-producing bacteria for struvite, and non-contrast CT as first imaging choice.
- Expects uric acid stones to appear on plain abdominal X-ray like calcium stones
- Attributes struvite stone formation to any UTI rather than specifically urease-producing bacteria
Cystic Kidney Diseases
ADPKD PKD1/2 variants and berry aneurysm risk, ARPKD with congenital hepatic fibrosis, and medullary sponge kidney versus progressive medullary cystic disease.
- Attributes all ADPKD to PKD1 without recognizing the PKD2 variant and its milder phenotype
- Overlooks congenital hepatic fibrosis as a defining feature of ARPKD
Renal Cell Carcinoma
Proximal tubule origin of clear cell RCC, polycythemia and hypercalcemia paraneoplastics, and VHL as a tumor suppressor stabilizing HIF-1α.
- Misidentifies the cell of origin of clear cell RCC as collecting duct rather than proximal tubule
- Associates RCC paraneoplastic syndrome with anemia rather than polycythemia or hypercalcemia
Wilms Tumor
Pediatric abdominal mass that does not cross midline, WT1 mutation in WAGR syndrome, and IGF2/WT2 locus in Beckwith-Wiedemann.
- Attributes midline-crossing on abdominal imaging to Wilms tumor rather than neuroblastoma
- Attributes Beckwith-Wiedemann syndrome to WT1 rather than the IGF2/WT2 locus at 11p15
Urothelial (Transitional Cell) Carcinoma
Painless hematuria from transitional epithelium, aromatic amine exposure, and Schistosoma haematobium driving squamous cell — not transitional — bladder cancer.
- Associates urothelial carcinoma with painful rather than painless hematuria
- Links Schistosoma haematobium to transitional cell carcinoma rather than squamous cell carcinoma of the bladder
Pyelonephritis
WBC casts as the pathognomonic urinalysis finding, focal polar scarring with calyceal blunting in chronic disease, and xanthogranulomatous variant mimicking tumor.
- Attributes WBC casts on urinalysis to cystitis rather than pyelonephritis or AIN
- Expects uniform cortical thinning in chronic pyelonephritis rather than focal polar scarring with calyceal blunting
Vesicoureteral Reflux (VUR)
Incompetent ureterovesical junction diagnosed by VCUG, graded severity with DMSA scarring, and reflux nephropathy causing hypertension and CKD from recurrent infection.
- Confuses ultrasound with VCUG/DMSA as the diagnostic tools for VUR and its sequelae
- Confuses obstruction with incompetence as the mechanism of VUR
Urinary Incontinence (Stress, Urge, Overflow, Mixed)
Sphincter weakness versus detrusor overactivity versus overflow with high post-void residual, and β3-agonist mirabegron versus anticholinergics for urge incontinence.
- Confuses the mechanism of stress incontinence (sphincter weakness) with urge incontinence (detrusor overactivity)
- Confuses overflow incontinence presentation with urge incontinence rather than recognizing dribbling with high post-void residual
Hyponatremia (Hypo-/Eu-/Hypervolemic)
Stepwise workup by serum osmolality then urine osmolality then volume status, SIADH with concentrated urine despite hyponatremia, and osmotic demyelination from overcorrection.
- Underestimates the danger of rapid sodium correction and its link to osmotic demyelination syndrome
- Skips serum osmolality as the first step in hyponatremia workup and jumps directly to volume assessment
Hypernatremia and DI
Free water deficit causing hypernatremia, DDAVP response distinguishing central from nephrogenic DI, and cerebral edema risk from overly rapid correction.
- Confuses the DDAVP response in central vs nephrogenic DI, missing that nephrogenic DI does not respond to exogenous ADH
- Advocates rapid correction of hypernatremia without recognizing the risk of cerebral edema from overly fast free water repletion
Hyperkalemia
Peaked T waves as earliest ECG change, calcium gluconate stabilizes membrane without lowering potassium, and insulin drives intracellular shift.
- Misidentifies QRS widening as the earliest ECG change in hyperkalemia rather than peaked T waves
- Confuses calcium gluconate's membrane-stabilizing effect with potassium-lowering activity
Hypokalemia
U waves on ECG, refractory hypokalemia from unrecognized hypomagnesemia, and vomiting causes renal — not gastric — potassium loss via alkalosis.
- Confuses the U wave of hypokalemia with QT prolongation rather than recognizing it as a separate post-T deflection
- Attributes hypokalemia from vomiting to direct gastric potassium loss rather than secondary renal wasting from alkalosis and aldosterone
Hypercalcemia and Hypocalcemia
Primary hyperparathyroidism dominates outpatient hypercalcemia while malignancy dominates inpatient; QT shortens in hypercalcemia and lengthens in hypocalcemia.
- Confuses the most common cause of hypercalcemia by clinical setting, attributing outpatient hypercalcemia to malignancy rather than primary hyperparathyroidism
- Reverses the ECG QT interval changes for hypercalcemia vs hypocalcemia
Metabolic Acidosis (AG vs Non-AG)
Anion gap calculation, MUDPILES versus HARDASS differentials, Winter's formula for expected compensation, and delta-delta ratio for hidden mixed disorders.
- Misapplies the anion gap formula by misclassifying bicarbonate's role in the calculation
- Accepts any low PCO₂ as appropriate compensation in metabolic acidosis without applying Winter's formula to detect mixed disorders
Renal Tubular Acidosis (Types 1, 2, 4)
Type 1 alkaline urine with hypokalemia, type 2 normalizes at steady state, and type 4 gives hyperkalemia from aldosterone deficiency — not an H⁺ pump defect.
- Expects persistently alkaline urine in type 2 RTA rather than understanding that urine pH normalizes at steady state unlike type 1
- Predicts hypokalemia in type 4 RTA rather than hyperkalemia from aldosterone deficiency
Metabolic Alkalosis
Urine chloride — not sodium — classifies saline-responsive versus resistant alkalosis, and aldosterone perpetuates vomiting-induced alkalosis beyond initial acid loss.
- Uses urine sodium instead of urine chloride to classify saline-responsive vs saline-resistant metabolic alkalosis
- Assumes unlimited respiratory compensation in metabolic alkalosis rather than recognizing the hypoxia-driven ceiling of ~55–60 mmHg PCO₂
Respiratory Acidosis / Alkalosis and Mixed Disorders
Acute versus chronic compensation magnitudes for respiratory disorders, and salicylate toxicity produces mixed respiratory alkalosis plus metabolic acidosis.
- Confuses acute vs chronic compensation magnitude for respiratory acid-base disorders
- Confuses salicylate toxicity as pure metabolic acidosis rather than the classic mixed respiratory alkalosis + metabolic acidosis
Loop Diuretics
NKCC2 blockade in the TAL causes hypercalciuria and hypokalemia; OH DANG side effects; synergistic ototoxicity with aminoglycosides.
- Confuses loop diuretic target as Na/K-ATPase rather than NKCC2 in the thick ascending limb
- Confuses loop diuretics with thiazides regarding calcium handling, missing that loops cause hypercalciuria
Thiazide Diuretics
NCC blockade in the DCT causes hypocalciuria via indirect Na/Ca exchange; Hyper-GLUC adverse effects; paradoxical use in nephrogenic DI.
- Confuses thiazide calcium sparing as a direct effect rather than an indirect consequence of intracellular Na depletion driving Na/Ca exchange
- Confuses thiazide use in nephrogenic DI as harmful rather than paradoxically beneficial
Potassium-Sparing Diuretics
MRAs block aldosterone receptor while ENaC blockers act directly on the channel; spironolactone anti-androgenic effects are class-specific; dual role in hyperaldosteronism and heart failure.
- Confuses ENaC blockers (amiloride, triamterene) with MRAs (spironolactone, eplerenone), missing their distinct mechanisms
- Attributes spironolactone's anti-androgenic side effects to the entire potassium-sparing diuretic class
Osmotic Diuretics (Mannitol)
Mannitol expands intravascular volume first — contraindicated in heart failure — then osmotically obligates water loss in the PCT and loop.
- Confuses mannitol as immediately volume-depleting, missing its initial intravascular volume expansion that contraindicates use in heart failure and pulmonary edema
- Misidentifies the primary site of mannitol action as the collecting duct rather than the proximal tubule and loop of Henle
Carbonic Anhydrase Inhibitors (Acetazolamide)
Acetazolamide blocks PCT bicarbonate reclamation, causing hyperchloremic metabolic acidosis, with indications spanning glaucoma, altitude sickness, and pseudotumor cerebri.
- Confuses acetazolamide as causing metabolic alkalosis rather than hyperchloremic metabolic acidosis
- Missing the multi-system clinical indications for acetazolamide beyond its renal effects
ACE Inhibitors and ARBs — Renal Effects
ACEi and ARBs dilate the efferent arteriole to reduce intraglomerular pressure; bilateral RAS makes this the sole GFR-maintaining mechanism; cough is bradykinin-mediated and ARB-absent.
- Confuses ACEi as safe in bilateral RAS, missing that efferent arteriolar tone is the sole GFR-maintaining mechanism in that setting
- Incorrectly interprets any creatinine rise after ACEi initiation as a reason to discontinue the drug
See how your Anki deck covers Renal.
Upload your deck for a free audit →